Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China

RecruitingOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

April 2, 2023

Primary Completion Date

December 1, 2023

Study Completion Date

May 1, 2024

Conditions
Ischemic Stroke
Interventions
DRUG

Tenecteplase

Thrombolysis wtih rhTNK-tPA

DRUG

Alteplase

Thrombolysis wtih rt-PA

Trial Locations (1)

Unknown

RECRUITING

Xin Chen, Shanghai

All Listed Sponsors
collaborator

Keshiketeng Banner Traditional Chinese Medicine Mongolian Medicine Hospitalorem Ipsum

UNKNOWN

collaborator

Nanshi Hospital of Nanyang

UNKNOWN

collaborator

First Affiliated Hospital of Ningbo University

NETWORK

collaborator

Jilin Liuhe Hospital

UNKNOWN

collaborator

Shenyang Fifth People's hospital

UNKNOWN

collaborator

Shanghai East Hospita

UNKNOWN

collaborator

Shanghai 10th People's Hospital

OTHER

collaborator

Shanghai Fifth People's Hospital

UNKNOWN

collaborator

Shanghai Pudong Gongli hospital

UNKNOWN

collaborator

Shanghai Neuromedical Center

UNKNOWN

collaborator

Shanghai Fourth People's Hospital

UNKNOWN

collaborator

Shanghai Pudong People's Hospital

UNKNOWN

collaborator

Shanghai Putuo District Center Hospital

OTHER

collaborator

Shenyang Fushun general hospital of mining bureau

UNKNOWN

collaborator

Yantai Affliated Hosiptal of Binzhou Medical University

UNKNOWN

collaborator

Shanghai Ninth People's Hospital Huangpu Branch

UNKNOWN

collaborator

Shanghai Deji Hospital

UNKNOWN

collaborator

Ruijin Hospital Luwan Branch

OTHER

lead

Huashan Hospital

OTHER

NCT06078995 - Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China | Biotech Hunter | Biotech Hunter